Results 111 to 120 of about 5,406 (200)

Olanzapine (10 mg vs 5 mg vs 2.5 mg) for the prophylaxis of chemotherapy-induced nausea and vomiting (CINV) - a systematic review and network meta-analysis. [PDF]

Support Care Cancer
Chow R, Zhang D, Chai GW, Yuen M, Lu A, Fortuna V, Talwar S, Boldt G, Lock M, Lee SF, Eng L, Iihara H, Affronti ML, Saito M, Aapro M, Hesketh PJ, Scotté F, Ruhlmann CH, Leigh J, MASCC Antiemetic Study Group.   +19 more
europepmc   +1 more source

Depression, Nutritional Status, and Substance P/NK-1R Biomarkers in Dysmenorrhea: A Randomized Crossover Trial. [PDF]

Depress Anxiety
Mehboob R, Shahid I, John A, Ahmad S, Mehboob Z, Alahmadi SA, Nasief H, Alwazzan A, Khadawardi KA.   +8 more
europepmc   +1 more source

Perioperative substance P/NK1R pharmacology: from PONV control to a testable cancer neuro-immune hypothesis. [PDF]

Front Immunol
Zhao J, Liu Z, Wang J.
europepmc   +1 more source

Targeting Circadian Rhythm Disruption in Glaucoma: PTGDS Mediates Trabecular Meshwork Fibrosis and Is Therapeutically Targeted by Aprepitant. [PDF]

Transl Vis Sci Technol
Yuan H, Che Y, Zhang Y, Cai Z, Ping YT, Wang X, Yang Y.   +6 more
europepmc   +1 more source

Spray-freeze-drying aprepitant with hydroxypropyl cellulose increases nasal bioavailability. [PDF]

Int J Pharm X
Rautenberg A, Bühlbecker P, Kožák J, Chrétien C, Pellequer Y, Wunderling K, Stoyanov E, Pfeifer A, Lamprecht A.   +8 more
europepmc   +1 more source

Postoperative nausea and vomiting: current concepts, management strategies, and future perspectives. [PDF]

Front Pharmacol
Qiu L, Alhaskawi A, Abdo Moqbel SA, Yuan H.   +3 more
europepmc   +1 more source

Investigating the effects of olanzapine on appetite and weight in patients with cancer in a systematic review. [PDF]

Discov Oncol
Renaux Torres MC, Smati K, Noujaim P, Martin S, Gigante E, Brugel M, Carlier C, Djerada Z, Perrier M, Bertin É, Bouché O, Coutureau C, Slimano F.   +12 more
europepmc   +1 more source

Comparative effectiveness and safety of ondansetron-based dual versus triple antiemetic regimens for chemotherapy-induced nausea and vomiting. [PDF]

Medicine (Baltimore)
Yu X, Yuan Y, Qiao G, Zheng W, Liu Z, Mao J, Yu L, Deng Z, Lin H, Zhang J.   +9 more
europepmc   +1 more source

Delayed and long-delayed chemotherapy-induced nausea and vomiting in moderately emetogenic chemotherapy: a scoping review of reporting gaps. [PDF]

ESMO Open
Iimura Y, Chow R, Watanabe D, Hayashi T, Kuroda S, Jordan K, Ruhlmann CH, Molassiotis A, Affronti ML, Scotté F, Iihara H, MASCC Antiemetic Study Group.   +11 more
europepmc   +1 more source

Structure-Guided Repurposing of Approved Drugs Identifies Aprepitant and Mavorixafor as Putative δ-Opioid Receptor Agonist Candidates. [PDF]

Int J Mol Sci
Buccheri R, Reale C, Coco A, Parenti C, Pasquinucci L, Rescifina A.   +5 more
europepmc   +1 more source